Pub. Date : 2021 Jun 14
PMID : 34125313
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | RECENT FINDINGS: Four FDA-approved drugs have significant activity against ROS1+ NSCLC: crizotinib, ciritinib, lorlatinib, and entrectinib. | Crizotinib | ROS proto-oncogene 1, receptor tyrosine kinase | Homo sapiens |